share_log

Agios Pharmaceuticals | 8-K: Agios Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights

SEC ·  Feb 15, 2024 20:07
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.